Buprenorphine for pain in children with sickle cell disease
Part of Blood & lymphatic, Genetic & congenital, Pain clinical trials.
This study tests a pain medicine called buprenorphine for kids and young adults with sickle cell disease who are having a pain crisis. It aims to see if it helps control pain safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (confirmed by a blood test)
- You are between 12 and 22 years old
- You weigh more than 110 pounds (50 kg)
- You are currently having a sickle cell pain crisis
- If you can become pregnant, you must have a negative pregnancy test during this hospital stay
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a low dose of ketamine, a pain medicine, can safely reduce pain during a sickle cell crisis in the emergency department. It aims to provide quicker pain relief for people with sickle cell disease.
This trial tests a new medicine, CSL889, for people with sickle cell disease who are currently having a pain crisis (vaso-occlusive crisis). The goal is to see if it safely helps reduce the pain and speed recovery.
This trial tests a special painkiller called sufentanil given as a nasal spray to children with sickle cell disease who are having a severe pain crisis. It aims to see if this nasal spray works better or as well as usual pain treatment to quickly reduce pain in the emergency room.
This study tests a low-dose form of buprenorphine (a medicine for pain) placed inside the cheek. It is designed for people who have never taken opioids before, to see how well it works for pain and how likely it is to be misused.
This study tests whether a low-dose of ketamine (a pain medicine) can help children and young adults with sickle cell disease who are in a pain crisis. It aims to provide better pain relief while avoiding some side effects of standard painkillers.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
Hear when a new Sickle Cell Anemia in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.